| 0.4 |
1.8 |
GO:0035262 |
gonad morphogenesis(GO:0035262) |
| 0.3 |
1.4 |
GO:0033326 |
cerebrospinal fluid secretion(GO:0033326) |
| 0.3 |
1.4 |
GO:0021698 |
cerebellar cortex structural organization(GO:0021698) |
| 0.3 |
0.9 |
GO:0002842 |
T cell mediated immune response to tumor cell(GO:0002424) regulation of T cell mediated immune response to tumor cell(GO:0002840) positive regulation of T cell mediated immune response to tumor cell(GO:0002842) |
| 0.3 |
1.7 |
GO:0045583 |
regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
| 0.3 |
1.0 |
GO:0046552 |
eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.3 |
1.5 |
GO:1903690 |
negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
| 0.2 |
0.7 |
GO:0070315 |
G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.2 |
0.6 |
GO:0003360 |
brainstem development(GO:0003360) |
| 0.2 |
1.1 |
GO:0035743 |
CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
| 0.2 |
0.5 |
GO:0010757 |
negative regulation of plasminogen activation(GO:0010757) |
| 0.2 |
0.5 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.2 |
0.5 |
GO:1904685 |
positive regulation of metalloendopeptidase activity(GO:1904685) |
| 0.2 |
0.8 |
GO:0060838 |
lymphatic endothelial cell fate commitment(GO:0060838) regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.1 |
0.4 |
GO:0033566 |
gamma-tubulin complex localization(GO:0033566) |
| 0.1 |
2.7 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.1 |
0.3 |
GO:0040009 |
regulation of growth rate(GO:0040009) |
| 0.1 |
0.2 |
GO:0072076 |
nephrogenic mesenchyme development(GO:0072076) |
| 0.1 |
0.5 |
GO:0021586 |
pons maturation(GO:0021586) |
| 0.1 |
0.6 |
GO:2000298 |
regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
| 0.1 |
0.4 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 0.1 |
0.8 |
GO:0042769 |
DNA damage response, detection of DNA damage(GO:0042769) |
| 0.1 |
0.3 |
GO:0001580 |
detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
| 0.1 |
0.5 |
GO:0034421 |
post-translational protein acetylation(GO:0034421) |
| 0.1 |
0.7 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.1 |
0.6 |
GO:0032596 |
protein transport into membrane raft(GO:0032596) |
| 0.1 |
0.4 |
GO:2000313 |
fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060825) regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation(GO:2000313) |
| 0.1 |
0.3 |
GO:0002925 |
regulation of dendritic cell cytokine production(GO:0002730) positive regulation of humoral immune response mediated by circulating immunoglobulin(GO:0002925) regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) detection of peptidoglycan(GO:0032499) negative regulation of interleukin-18 production(GO:0032701) |
| 0.1 |
0.3 |
GO:1901731 |
calcium-mediated signaling using extracellular calcium source(GO:0035585) positive regulation of platelet aggregation(GO:1901731) |
| 0.1 |
0.3 |
GO:1903984 |
positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.1 |
0.3 |
GO:0055071 |
cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) manganese ion homeostasis(GO:0055071) |
| 0.1 |
0.4 |
GO:1900186 |
negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.1 |
0.6 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.1 |
1.7 |
GO:0032897 |
negative regulation of viral transcription(GO:0032897) |
| 0.1 |
0.3 |
GO:0060907 |
positive regulation of macrophage cytokine production(GO:0060907) |
| 0.1 |
0.4 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.2 |
GO:0090285 |
negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.1 |
0.3 |
GO:0070213 |
protein auto-ADP-ribosylation(GO:0070213) |
| 0.1 |
0.8 |
GO:0071257 |
cellular response to electrical stimulus(GO:0071257) |
| 0.1 |
0.2 |
GO:0060282 |
positive regulation of oocyte development(GO:0060282) |
| 0.1 |
0.5 |
GO:0030579 |
ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
| 0.1 |
0.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.2 |
GO:0035574 |
histone H4-K20 demethylation(GO:0035574) |
| 0.1 |
0.2 |
GO:2000686 |
regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
| 0.1 |
0.2 |
GO:0007525 |
somatic muscle development(GO:0007525) |
| 0.1 |
0.8 |
GO:0046643 |
regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
| 0.1 |
1.2 |
GO:0071392 |
cellular response to estradiol stimulus(GO:0071392) |
| 0.1 |
1.1 |
GO:0060236 |
regulation of mitotic spindle organization(GO:0060236) |
| 0.1 |
0.2 |
GO:0001920 |
negative regulation of receptor recycling(GO:0001920) |
| 0.1 |
0.6 |
GO:0002176 |
male germ cell proliferation(GO:0002176) |
| 0.1 |
1.1 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 |
0.2 |
GO:0010512 |
negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.1 |
0.1 |
GO:0090529 |
barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) |
| 0.1 |
0.5 |
GO:0070933 |
histone H4 deacetylation(GO:0070933) |
| 0.1 |
0.2 |
GO:0001661 |
conditioned taste aversion(GO:0001661) |
| 0.1 |
0.3 |
GO:0019236 |
response to pheromone(GO:0019236) |
| 0.1 |
0.2 |
GO:0097527 |
necroptotic signaling pathway(GO:0097527) |
| 0.0 |
0.1 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.4 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) negative regulation of glycogen metabolic process(GO:0070874) |
| 0.0 |
0.4 |
GO:0031053 |
primary miRNA processing(GO:0031053) |
| 0.0 |
0.7 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.0 |
0.1 |
GO:0003169 |
coronary vein morphogenesis(GO:0003169) |
| 0.0 |
0.1 |
GO:0036091 |
positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
| 0.0 |
0.4 |
GO:0098535 |
de novo centriole assembly(GO:0098535) |
| 0.0 |
0.4 |
GO:0038033 |
positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.0 |
0.2 |
GO:2000812 |
regulation of barbed-end actin filament capping(GO:2000812) |
| 0.0 |
0.1 |
GO:1900275 |
negative regulation of phospholipase C activity(GO:1900275) |
| 0.0 |
0.4 |
GO:0070102 |
interleukin-6-mediated signaling pathway(GO:0070102) |
| 0.0 |
0.2 |
GO:0035616 |
histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 |
0.0 |
GO:0032472 |
Golgi calcium ion transport(GO:0032472) |
| 0.0 |
0.1 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.0 |
0.1 |
GO:0002408 |
myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.0 |
0.8 |
GO:0035873 |
lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.0 |
0.1 |
GO:1903225 |
negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.0 |
0.2 |
GO:0045053 |
protein retention in Golgi apparatus(GO:0045053) |
| 0.0 |
0.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.0 |
0.5 |
GO:1904293 |
negative regulation of ERAD pathway(GO:1904293) |
| 0.0 |
0.2 |
GO:0044314 |
protein K27-linked ubiquitination(GO:0044314) |
| 0.0 |
0.1 |
GO:2000819 |
regulation of nucleotide-excision repair(GO:2000819) |
| 0.0 |
0.1 |
GO:0046077 |
dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine ribonucleoside diphosphate metabolic process(GO:0009193) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) UDP metabolic process(GO:0046048) dUDP metabolic process(GO:0046077) |
| 0.0 |
0.2 |
GO:0021914 |
negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.0 |
0.2 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) regulation of dendritic spine maintenance(GO:1902950) positive regulation of dendritic spine maintenance(GO:1902952) |
| 0.0 |
0.2 |
GO:0007089 |
traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.0 |
0.2 |
GO:1900029 |
positive regulation of ruffle assembly(GO:1900029) |
| 0.0 |
0.4 |
GO:0032048 |
cardiolipin metabolic process(GO:0032048) |
| 0.0 |
0.3 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.0 |
0.1 |
GO:0032430 |
positive regulation of phospholipase A2 activity(GO:0032430) |
| 0.0 |
0.1 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.0 |
0.3 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.0 |
0.1 |
GO:1900127 |
positive regulation of hyaluronan biosynthetic process(GO:1900127) |
| 0.0 |
0.4 |
GO:0070986 |
left/right axis specification(GO:0070986) |
| 0.0 |
0.4 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.0 |
0.5 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.0 |
0.8 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.0 |
0.2 |
GO:0033353 |
S-adenosylmethionine cycle(GO:0033353) |
| 0.0 |
0.2 |
GO:0090527 |
actin filament reorganization(GO:0090527) |
| 0.0 |
0.2 |
GO:1904338 |
regulation of dopaminergic neuron differentiation(GO:1904338) |
| 0.0 |
0.1 |
GO:0097461 |
ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) |
| 0.0 |
0.1 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.0 |
0.3 |
GO:0036120 |
response to platelet-derived growth factor(GO:0036119) cellular response to platelet-derived growth factor stimulus(GO:0036120) |
| 0.0 |
0.2 |
GO:0015015 |
heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
| 0.0 |
0.1 |
GO:0060040 |
retinal bipolar neuron differentiation(GO:0060040) |
| 0.0 |
0.1 |
GO:0015793 |
glycerol transport(GO:0015793) |
| 0.0 |
0.1 |
GO:0032829 |
regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.0 |
0.1 |
GO:0033601 |
positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
| 0.0 |
0.1 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.0 |
0.1 |
GO:1900042 |
positive regulation of interleukin-2 secretion(GO:1900042) |
| 0.0 |
0.1 |
GO:0014029 |
neural crest formation(GO:0014029) |
| 0.0 |
0.2 |
GO:0042989 |
sequestering of actin monomers(GO:0042989) |
| 0.0 |
0.1 |
GO:0061365 |
positive regulation of triglyceride lipase activity(GO:0061365) |
| 0.0 |
0.2 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.0 |
0.1 |
GO:0043402 |
glucocorticoid mediated signaling pathway(GO:0043402) |
| 0.0 |
0.1 |
GO:0051490 |
negative regulation of filopodium assembly(GO:0051490) |
| 0.0 |
0.1 |
GO:0006348 |
chromatin silencing at telomere(GO:0006348) |
| 0.0 |
0.1 |
GO:1900365 |
positive regulation of mRNA polyadenylation(GO:1900365) |
| 0.0 |
0.1 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.0 |
0.1 |
GO:0006532 |
aspartate biosynthetic process(GO:0006532) |
| 0.0 |
0.1 |
GO:0060334 |
regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.2 |
GO:0019065 |
receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
| 0.0 |
0.3 |
GO:0032287 |
peripheral nervous system myelin maintenance(GO:0032287) |
| 0.0 |
0.2 |
GO:2000270 |
negative regulation of fibroblast apoptotic process(GO:2000270) |
| 0.0 |
0.2 |
GO:0021796 |
cerebral cortex regionalization(GO:0021796) |
| 0.0 |
0.5 |
GO:0006607 |
NLS-bearing protein import into nucleus(GO:0006607) |
| 0.0 |
0.7 |
GO:0051642 |
centrosome localization(GO:0051642) |
| 0.0 |
0.1 |
GO:0006624 |
vacuolar protein processing(GO:0006624) negative regulation of vacuolar transport(GO:1903336) |
| 0.0 |
0.3 |
GO:0070050 |
neuron cellular homeostasis(GO:0070050) |
| 0.0 |
0.2 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.3 |
GO:0001731 |
formation of translation preinitiation complex(GO:0001731) |
| 0.0 |
0.2 |
GO:0071157 |
negative regulation of cell cycle arrest(GO:0071157) |
| 0.0 |
0.1 |
GO:0006533 |
aspartate catabolic process(GO:0006533) D-amino acid catabolic process(GO:0019478) |
| 0.0 |
0.1 |
GO:0060032 |
smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) notochord regression(GO:0060032) |
| 0.0 |
0.5 |
GO:0000132 |
establishment of mitotic spindle orientation(GO:0000132) |
| 0.0 |
0.5 |
GO:0048536 |
spleen development(GO:0048536) |
| 0.0 |
0.1 |
GO:0034239 |
regulation of macrophage fusion(GO:0034239) |
| 0.0 |
0.8 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.3 |
GO:0019369 |
drug metabolic process(GO:0017144) arachidonic acid metabolic process(GO:0019369) |
| 0.0 |
0.2 |
GO:0060363 |
cranial suture morphogenesis(GO:0060363) |
| 0.0 |
0.0 |
GO:0097089 |
methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.0 |
0.0 |
GO:0048633 |
positive regulation of skeletal muscle tissue growth(GO:0048633) |
| 0.0 |
0.2 |
GO:0050860 |
negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 |
0.1 |
GO:0060018 |
astrocyte fate commitment(GO:0060018) |
| 0.0 |
0.7 |
GO:0032611 |
interleukin-1 beta production(GO:0032611) |
| 0.0 |
0.1 |
GO:1900364 |
regulation of mRNA polyadenylation(GO:1900363) negative regulation of mRNA polyadenylation(GO:1900364) |
| 0.0 |
0.3 |
GO:0071786 |
endoplasmic reticulum tubular network organization(GO:0071786) |
| 0.0 |
0.3 |
GO:0006359 |
regulation of transcription from RNA polymerase III promoter(GO:0006359) |
| 0.0 |
0.1 |
GO:0097501 |
stress response to metal ion(GO:0097501) |
| 0.0 |
0.1 |
GO:0032292 |
myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
| 0.0 |
0.2 |
GO:0097151 |
positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
| 0.0 |
1.0 |
GO:0030148 |
sphingolipid biosynthetic process(GO:0030148) |
| 0.0 |
0.5 |
GO:0003301 |
physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.0 |
0.4 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.0 |
1.1 |
GO:0050772 |
positive regulation of axonogenesis(GO:0050772) |
| 0.0 |
0.1 |
GO:0031584 |
activation of phospholipase D activity(GO:0031584) |
| 0.0 |
0.1 |
GO:0070125 |
mitochondrial translational elongation(GO:0070125) |
| 0.0 |
0.2 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.0 |
0.1 |
GO:1902913 |
positive regulation of melanocyte differentiation(GO:0045636) positive regulation of neuroepithelial cell differentiation(GO:1902913) |
| 0.0 |
0.1 |
GO:0014883 |
transition between fast and slow fiber(GO:0014883) positive regulation of stem cell population maintenance(GO:1902459) |
| 0.0 |
0.1 |
GO:0031282 |
regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 |
0.3 |
GO:0045214 |
sarcomere organization(GO:0045214) |
| 0.0 |
0.1 |
GO:0097152 |
mesenchymal cell apoptotic process(GO:0097152) |
| 0.0 |
0.1 |
GO:0045899 |
positive regulation of RNA polymerase II transcriptional preinitiation complex assembly(GO:0045899) |
| 0.0 |
0.1 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.0 |
0.1 |
GO:2000672 |
negative regulation of motor neuron apoptotic process(GO:2000672) |
| 0.0 |
0.1 |
GO:0070535 |
histone H2A K63-linked ubiquitination(GO:0070535) |
| 0.0 |
0.1 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.0 |
0.2 |
GO:0046931 |
pore complex assembly(GO:0046931) |
| 0.0 |
0.0 |
GO:0048537 |
B cell lineage commitment(GO:0002326) mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.0 |
0.2 |
GO:0030970 |
retrograde protein transport, ER to cytosol(GO:0030970) |
| 0.0 |
0.1 |
GO:0046349 |
amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.2 |
GO:1901522 |
positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
| 0.0 |
0.1 |
GO:0030813 |
positive regulation of nucleotide catabolic process(GO:0030813) positive regulation of glycolytic process(GO:0045821) positive regulation of cofactor metabolic process(GO:0051194) positive regulation of coenzyme metabolic process(GO:0051197) |
| 0.0 |
0.1 |
GO:0018243 |
protein O-linked glycosylation via threonine(GO:0018243) |
| 0.0 |
0.0 |
GO:0006933 |
negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.0 |
0.1 |
GO:0042670 |
retinal cone cell differentiation(GO:0042670) retinal cone cell development(GO:0046549) |
| 0.0 |
0.2 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.0 |
GO:0001803 |
antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
